Skip to main content
ZheJiang Tailin Bioengineering Co.,Ltd logo

ZheJiang Tailin Bioengineering Co.,Ltd — Investor Relations & Filings

Ticker · 300813 ISIN · CNE100003S89 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 990 across all filing types
Latest filing 2026-03-26 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300813

About ZheJiang Tailin Bioengineering Co.,Ltd

https://www.tailingood.com

ZheJiang Tailin Bioengineering Co.,Ltd. specializes in the research, development, and manufacturing of high-tech equipment for life sciences and pharmaceutical engineering. The company provides integrated solutions for microbial control, sterility testing, and aseptic processing. Its core product portfolio includes sterility test canisters and pumps, microbial limit testing systems, and hydrogen peroxide vapor (VHP) decontamination units. Tailin also develops advanced isolator technology for containment and aseptic applications, alongside analytical instruments such as Total Organic Carbon (TOC) analyzers and filter integrity testers. These products are designed to meet international regulatory standards, including GMP, USP, and EP. The company serves sectors such as biopharmaceuticals, medical devices, and laboratory research, focusing on product safety and quality through specialized engineering and microbial detection technologies.

Recent filings

Filing Released Lang Actions
关于公司及全资子公司向银行申请综合授信额度的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Zhejiang Tailin Biotechnology Co., Ltd. regarding the company's and its wholly-owned subsidiaries' application for a comprehensive credit facility from banks. It details the credit amount, usage, authorization, and approval by the board of directors. There is no financial data, earnings, or report attached or referenced as being published. The content focuses on financing activities and credit arrangements. Therefore, this fits the category of Capital/Financing Update (CAP). The document length is short and it is not a report publication announcement or certification. Hence, the classification is CAP with high confidence.
2026-03-26 Chinese
关于2025年度会计师事务所履职情况评估报告
Audit Report / Information Classification · 95% confidence The document is titled as an evaluation report on the performance of the accounting firm Tianjian for the fiscal year 2025. It details the qualifications, independence, quality management, and audit work plan of the accounting firm engaged by Zhejiang Tailin Biotechnology Co., Ltd. The content focuses on the audit firm's performance and compliance rather than presenting financial statements or audit results themselves. The document length is 2809 characters, which is relatively short and reads like an assessment or report on the auditor's work rather than a full audit report or annual report. It does not contain financial statements or substantive financial data but rather an evaluation of the auditor's duties and quality control. This fits the definition of an Audit Report / Information (AR) as it is a standalone audit-related report about the auditor's performance and compliance, not the full annual report or financial statements. Therefore, the correct classification is AR with high confidence. FY 2025
2026-03-26 Chinese
2025年度非经营性资金占用及其他关联资金往来情况汇总表
Regulatory Filings Classification · 95% confidence The document is a summary table detailing non-operating fund occupation and other related party fund transactions for the year 2025, prepared by Zhejiang Tailin Biotechnology Co., Ltd. It includes financial figures such as balances, interest, and repayments related to related parties and subsidiaries. The document is relatively short (1282 characters) and appears to be a specific financial disclosure related to related party transactions rather than a full financial report or announcement. It does not contain comprehensive financial statements or management discussion, nor is it an announcement of a report publication. It is a regulatory disclosure of related party transactions, which typically falls under Regulatory Filings (RNS) as it does not fit other specific categories like Annual Report, Interim Report, or Audit Report. Therefore, the best classification is Regulatory Filings (RNS).
2026-03-26 Chinese
2025年年度报告
Annual Report Classification · 100% confidence The document is titled as the "2025 年年度报告全文" which translates to "2025 Annual Report Full Text" for Zhejiang Tailin Bioengineering Co., Ltd. It contains detailed sections typical of an annual report, including company overview, financial data, management discussion and analysis, governance, and financial statements. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. It includes audited financial data, management discussion, and detailed business descriptions, consistent with an official annual report. Therefore, the document is classified as an Annual Report (10-K). FY 2025
2026-03-26 Chinese
关于取得专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from Zhejiang Tailin Biotechnology Co., Ltd. about obtaining two patent certificates. It includes details about the patents and states that the patents will not have a significant impact on recent operations but will enhance intellectual property protection and innovation. There is no financial data, no mention of annual or quarterly reports, no voting results, no management changes, no legal proceedings, or other regulatory filings. The document is an official announcement regarding intellectual property achievements, which does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is not a report publication announcement since it does not mention any report being published or attached. The best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2026-03-09 Chinese
关于取得专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (628 characters) from Zhejiang Tailin Biotechnology Co., Ltd. about obtaining three patent certificates by its subsidiaries. It includes details about the patents but does not contain financial data, management changes, or regulatory filings related to financial performance. It is a regulatory announcement about intellectual property achievements, not a financial report or management change. Given the nature and length, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-02-06 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.